Jane Street
RIGL icon

Jane Street’s Rigel Pharmaceuticals RIGL Stock Holding History

Jane Street’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$419K Sell
15,500
-15,600
-50% -$524K ﹤0.01% 8462
2025
Q4 		$1.33M Buy
31,100
+15,900
+105% +$599K ﹤0.01% 5558
2025
Q3 		$431K Buy
+15,200
New +$455K ﹤0.01% 8173
2022
Q3 		– Sell
-4,200
Closed -$47K – 10388
2022
Q2 		$47K Buy
+4,200
New +$84.4K ﹤0.01% 8943
2022
Q1 		– Sell
-2,450
Closed -$65K – 10987
2021
Q4 		$65K Sell
2,450
-10,890
-82% -$329K ﹤0.01% 9434
2021
Q3 		$484K Buy
13,340
+7,020
+111% +$276K ﹤0.01% 7342
2021
Q2 		$274K Buy
+6,320
New +$239K ﹤0.01% 8310

Other funds holding RIGL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return